AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
"It's a landscape in chaos right now."
Motley Fool Money
The Lack of the Envelope Math for Johnson and Johnson's Consumer Health Care Business
2min Snip
00:00
Summary
Transcript
Episode notes
The Wall Street Journal is reporting that Johnson and Johnson is planning to start the roadshow for its consumer health care business as early as this week. The spinoff IPO will be later this year for Kenview, the name chosen for the business familiar for products like Tylenol Band-Aids and Neutrogena. John Sutter: $40 billion valuation could be a little bit of a discount because when you look at all of the brand names they have out there, it's really impressive.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode